AmerisourceBergen Corp | ABC.USX
United States - USD

Stock Exchange: NYSE

Symbol: ABC

Sector: Healthcare

Industry: Medical Distribution

About AmerisourceBergen Corp

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

AmerisourceBergen Corp Stats

Previous close:Daily change:
180.39-0.23%
52-Week High:52-Week Low:
194.79135.14
Market Cap:Beta:
36.1 Billion0.56

AmerisourceBergen Corp Key Financials

P/E Ratio:Revenues:Revenue Growth:Gross Margin:
21.922254.4 Billion11.50%3.38%
Dividend Yield:Net Income:Earnings Growth:Net Income Margin:
1.08%1.7 Billion22.40%0.66%
P/E Ratio:Revenues:
21.922254.4 Billion
Dividend Yield:Net Income:
1.08%1.7 Billion
Revenue Growth:Gross Margin:
11.50%3.38%
Earnings Growth:Net Income Margin:
22.40%0.66%
ParametersStocks Investing
Stock CurrencyUSD
Dividend PayingYes
Fractional SharesNo
Maximum Shares100 Shares
Tick value per 1 share0.01 USD
Trading Commission0%
Minimum Price Increment0.01
Limit and Stop Levels0.0
Negative balance protectionNo
Swap free days allowanceN/A
Own the underlying AssetNo
Platform symbolABC.USX
Disclaimer: This material is provided by third-party data sources as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in CFDs and Physical Stocks products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information presented here.
Avertissement relatif aux investissements à haut risque : les contrats de différence (« CFD ») sont des produits financiers complexes qui se négocient sur marge. Les opérations sur les CFD sont assorties d'un niveau de risque élevé. Vous risquez de perdre la totalité de votre capital. Ces produits sont susceptibles de ne pas être adaptés à tout le monde et il convient de vous assurer de bien comprendre les risques encourus. Si nécessaire, sollicitez l'avis d'un expert indépendant et n'investissez que des fonds dont vous pouvez assumer la perte. Nous vous invitons à réfléchir mûrement à la pertinence de ce type d'opérations, au regard de l'ensemble des circonstances pertinentes et de vos ressources personnelles. Nous déconseillons aux clients de mobiliser la totalité du solde de leur compte en vue de satisfaire aux exigences de marge. Les clients ont la possibilité de minimiser leur niveau d'exposition en demandant une modification du plafond de l'effet de levier. Pour obtenir de plus amples informations, veuillez vous reporter au document de divulgation des risques de HYCM.
Avis de non-responsabilité : Le contenu de cette page sert un propos purement informatif et n'a pas valeur de recommandation ou de conseil. Toute indication de performance passée ou simulation sur la base de performance passée incluse dans les annonces publiées par HYCM n'est pas un indicateur fiable des résultats futurs. Le client assume l'entière responsabilité de toutes les transactions ou investissements qui sont effectués à HYCM.
Restrictions régionales : nous n'offrons pas nos services aux résidents de certaines juridictions telles que l'Afghanistan, la Belgique, Hong Kong, les États-Unis d'Amérique et d'autres régions. Pour obtenir davantage d'informations, veuillez consulter notre
Centre d'aide

HYCM Limited is authorized and regulated under the Dubai Financial Services Authority with license number F000048.

Copyright © 2024 HYCM.